Filana Therapeutics CEO Richard Barry acquires $78,196 of common shares

FLNA•2026-09-30

Filana Therapeutics President and CEO Richard Barry bought 93,091 common shares on the open market at $0.84 per share, bringing his indirect holdings through a trust to 1,031,151 shares.

1. Open-market purchase

Barry reported an open-market purchase of 93,091 common shares at $0.84 per share. His holdings rose to 1,031,151 shares held indirectly through a trust.

Sources

Filana Therapeutics CEO Richard Barry acquires $78,196 of common shares

Sec

Filana Therapeutics CEO Richard Barry acquires $78,196 of common shares

1. Open-market purchase

Related News

First Citizens BancShares schedules third-quarter earnings call

CTO Realty Growth closes $1 billion amended unsecured credit facility led by KeyBank

Alamo Group ceases production of Dixie Chopper brand, expects $15 million-$20 million Q3 charges

Sources

Filana Therapeutics CEO Richard Barry acquires $78,196 of common shares

Standard BioTools switches Mass Cytometry sale to Element Biosystems for $5.5 million cash

TAPI names Serge Rogasik CEO